UHS Universal Health Services, Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 7, 2026UHS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
UHS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Dec. 16, 2009 | 2-for-1 | Forward |
| June 4, 2001 | 2-for-1 | Forward |
| May 20, 1996 | 2-for-1 | Forward |
| July 5, 1983 | 2-for-1 | Forward |
About Universal Health Services, Inc. Common Stock Company overview from Wikipedia
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Company history
Alan B. Miller, who currently serves as the company's Executive Chairman, founded Universal Health Services, Inc. in 1979. Within 18 months of its founding, UHS owned four hospitals and had management contracts with two additional hospitals.
In 1979, UHS entered Las Vegas with the purchase of Valley Hospital.
In 1980, the company chose its first Board of Directors. In 1981, UHS held its initial public offering. In 1982, UHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation purchased hospitals from a nonprofit religious organization. In 1983, UHS purchased Qualicare, Inc. for more than $116 million. The purchase included 11 acute care hospitals and four behavioral health hospitals. In 1986, UHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry.
In 1991, UHS stock trading moved from NASDAQ to NYSE.
In November 2010, UHS reached an agreement in May to acquire Psychiatric Solutions, Inc. for $3.1 billion. In June 2012, UHS announced its plans to acquire Ascend Health Corporation for $517 million. In February 2014, UHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde Behavioral Health. In April of that year, UHS announced the acquisition of the Psychiatric Institute of Washington. In September of that year, UHS' stock joined the S&P 500 Index and acquired Cygnet Health Care Limited for approximately $335 million. In August 2015, UHS acquired Alpha Hospitals Holdings Limited for $148 million from private equity group C&C Alpha Group. In September of that year, UHS announced the acquisition of Foundations Recovery Network based in Brentwood, Tennessee for $350 million. In August 2016, UHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount. In December of that year, UHS acquired Cambian Group PLC's Adult Services Division. In July 2018, UHS announced its acquisition of the Danshell Group.
On September 28, 2020, Universal Health Services Inc. announced that its network went offline after an unspecified "IT security issue".
In September 2020, consistent with the company's long-standing succession plan, UHS announced that Alan B. Miller would step down as CEO in January 2021 and that President Marc D. Miller would be named CEO.
UHS ranked on the Fortune 500 in 2021, 2022 in 2023 and 2024, and 2025
UHS was named on the Fortune World's Most Admired List in 2025, 2024 2023, 2022, 2021 and 2020.
UHS has been named on the Forbes Global 2000 ranking in 2025. UHS is ranked at #1,090. Of the American companies on the ranking, UHS ranked #355 among U.S. companies and #23 among global Health Care Equipment and Services category. UHS has been on the ranking for 22 years, and in 2023 earned ‘Hall of Fame’ status.
In March 2026, UHS agreed to acquire online and mobile therapy service provider Talkspace for $835 million.
Controversies
Hospital licenses
The Centers for Medicare and Medicaid Services (CMS) threatened the Rancho Springs Medical Center (Murrieta) and Inland Valley Regional Medical Center (Wildomar) in California with decertification in June 2010 while the State of California warned of a possible hospital license revocation. Universal Health Services implemented a program to address all concerns and in November 2011 the two hospitals passed a CMS Certification Survey. As a result, CMS rescinded its termination notice and the California Department of Public Health withdrew its license revocation notice.
Allegations of noncompliance with same-sex visitation law
According to a petition started on Change.org by Terri-Ann Simonelli of Henderson, Nevada, Spring Valley Hospital (owned and operated by UHS) claimed that their policy required power of attorney for a same-sex partner to make medical decisions on behalf of their partner. If true, this would seemingly violate new Department of Health and Human Services rules enabling same-sex partners to make said decisions, with or without power of attorney.
Fraudulent Medicaid claims
In September 2012, UHS and its subsidiaries, Keystone Education and Youth Services LLC and Keystone Marion LLC d/b/a Keystone Marion Youth Center agreed to pay over $6.9 million to resolve allegations that they submitted false and fraudulent claims to Medicaid. Between October 2004 and March 2010, the entities allegedly provided substandard psychiatric counseling and treatment to adolescents in violation of the Medicaid requirements. The United States alleged that UHS falsely represented Keystone Marion Youth Center as a residential treatment facility providing inpatient psychiatric services to Medicaid enrolled children, when in fact it was a juvenile detention facility. The United States further alleged that neither a medical director nor licensed psychiatrist provided the required direction for psychiatric services or for the development of initial or continuing treatment plans. The settlement further resolved allegations that the entities filed false records or statements to Medicaid when they filed treatment plans that falsely represented the level of services that would be provided to the patients.
On July 10, 2020, the US Department of Justice announced a $122 million Fraudulent Claims case with "Universal Health Services, Inc., UHS of Delaware, Inc.(together, UHS), and Turning Point Care Center, LLC (Turning Point), a UHS facility located in Moultrie, Georgia, have agreed to pay a combined total of $122 million to resolve alleged violations of the False Claims Act for billing for medically unnecessary inpatient behavioral health services, failing to provide adequate and appropriate services, and paying illegal inducements to federal healthcare beneficiaries." From the announcement: "The government alleged that, between January 2006, and December 2018, UHS's facilities admitted federal healthcare beneficiaries who were not eligible for inpatient or residential treatment because their conditions did not require that level of care, while also failing to properly discharge appropriately admitted beneficiaries when they no longer required inpatient care. The government further alleged that UHS's facilities billed for services not rendered, billed for improper and excessive lengths of stay, failed to provide adequate staffing, training, and/or supervision of staff, and improperly used physical and chemical restraints and seclusion. In addition, UHS's facilities allegedly failed to develop and/or update individual assessments and treatment plans for patients, failed to provide adequate discharge planning, and failed to provide required individual and group therapy services in accordance with federal and state regulations.
Of the $117 million to be paid by UHS to resolve these claims, the federal government will receive a total of $88,124,761.27, and a total of $28,875,238.73 will be returned to individual states, which jointly fund state Medicaid programs."
BuzzFeed investigation
On December 7, 2016, BuzzFeed published a report detailing questionable practices within UHS psychiatric facilities. The report includes allegations of holding nonthreatening patients against their will, manipulative misinterpretation of patient testimonies to fit guidelines to involuntary confinement, aggressive staff layoffs and understaffing in hospitals, needless patient deaths due to understaffing and misprescription of medication, "violating a patient's right to be discharged or holding a patient without the proper documentation", and unnecessary extension of stay times to the maximum Medicare payout. UHS denied the conclusions of the report. UHS stock fell approximately 12% after publication.
According to BuzzFeed investigative reporter Rosalind Adams, UHS responded to the report by hiring "a global PR firm that offers specialized crisis management services... UHS didn't just implement a crisis PR plan. It also fired an employee that the company believed to have spoken to a reporter; it sued a former employee it alleges leaked damaging internal surveillance videos; it threatened to sue other employees; at least one facility held a series of town hall meetings to warn employees from speaking with us; it conducted "in-depth interviews" with nearly two dozen staff, then distributed a public apology that two of them signed; it enlisted one of the most powerful law firms in the United States; it built multiple, high-production-value websites specifically designed to overcome the reputational damage that our reporting might cause."
Cygnet Healthcare
A UK subsidiary, Cygnet Health Care, was the subject of a BBC investigation that found that staff had been taunting, provoking and scaring vulnerable people. It runs 140 mental health services across the UK. 85% of its services are "rated good or outstanding by our regulators". New admissions were banned at Cygnet Acer clinic after the Care Quality Commission found it unsafe to use. A patient hanged herself, others self harmed, ligature points were found where patients could hang themselves and too many of the staff were untrained to deal with the highly vulnerable patients at the clinic.
The company bought four inpatient units which were previously operated by the Danshell Group in 2018. All four were condemned by the Care Quality Commission which raised concerns about patients' "unexplained injuries" and high levels of restraint in 2019.
Laurel Oaks Behavior Health Center
On February 8, 2024, a lawsuit was filed against the company's Dothan, Alabama-based Laurel Oaks Behavioral Health Center and its CEO Janette Jackson which alleged that Laurel Oaks Behavior Health Center mishandled numerous incidents involving the assault of an eight-year-old boy residing in the facility. The boy was reportedly assaulted by his larger roommate while he residing at the facility for a week in 2022. Universal Health Services would be sued as well. The lawsuit also noted that a 40-year-old man was convicted in 2011 of sexually assaulting a teenage patient while employed at Laurel Oaks. A 17-year-old patient had been charged in 2014 with felony counts of first-degree sodomy as well.
Provo Canyon School
Provo Canyon School was the name two residential treatment centers operated by UHS before being shutdown by the Utah DHHS. The school was in media headlines for years as abuse was prominent throughout its history, including past owners. To name a few allegations, "using a cruel, unusual, or unnecessary practice on a child by withholding personal interaction, emotional response, or stimulation", and "depriving [children] (cilents) of water, rest, and the opportunity for toileting."
Additional allegations
On May 16, 2021, Detroit Free Press published an article alleging UHS partner St. Simons By The Sea (formerly Focus By The Sea) in St. Simons Island, Georgia recruited patients from a local soup kitchen for treatment that may have been coercive or medically unnecessary.(subscription required)
Facilities
Hospitals and medical centers
As of June 2024, the UCS website lists the following medical and acute care facilities in the United States.
California
Corona
Southwest Healthcare Corona Regional Medical Center
Murrieta
A Plus Urgent Care
Southwest Healthcare Rancho Springs Hospital
Temecula Valley Day Surgery
Palmdale
Southwest Healthcare Palmdale Regional Medical Center
Riverside
Riverside Medical Clinic
Temecula
Southwest Healthcare Temecula Valley Hospital
Wildomar
Southwest Healthcare Inland Valley Hospital
District of Columbia
Washington
The George Washington University Hospital
Cedar Hill Hospital Medical Center
Florida
Arcadia
Manatee Diagnostic Center (Arcadia)
Bradenton
ER at Bayshore Gardens
ER at Sun City Center
ER at Palma Sola
Lakewood Ranch Medical Center
Lakewood Ranch Medical Group
Manatee Diagnostic Center (Pointe West)
Manatee Diagnostic Center (Riverside)
Manatee Health
Manatee Memorial Hospital
Manatee Physician Alliance
Orlando
University Behaviorial Center
Parrish
Manatee Diagnostic Center (Parrish)
Royal Palm Beach
Palms Westside Clinic ASC
Sarasota
ER at Fruitville
Wellington
Wellington Physicians Alliance
West Palm Beach
Wellington Regional Medical Center
Westlake
ER at Westlake
Wimauma
ER at Sun City Center
Nevada
Henderson
ER at Green Valley Ranch
Henderson Hospital
Las Vegas
Centennial Hills Hospital Medical Center
Elite Medical Center
ER at Blue Diamond
ER at Desert Springs
ER at West Craig Road
Spring Valley Hospital Medical Center
Summerlin Hospital Medical Center
Valley Health Physician Alliance
Valley Health Specialty Hospital
Valley Hospital Medical Center
North Las Vegas
ER at North Las Vegas
ER at Valley Vista
Pahrump
Desert View Hospital
Reno
ER at Damonte Ranch
ER at McCarran NW
Northern Nevada Sierra Medical Center
Quail Surgical and Pain Management Center
Sparks
ER at Spanish Springs
Northern Nevada Medical Center
Northern Nevada Medical Group
Oklahoma
Enid
St. Mary's Physician Associates
St. Mary's Regional Medical Center
Pennsylvania
King of Prussia
Eastern Pennsylvania Physician Alliance
UHS Corporate
South Carolina
Aiken
Aiken Physicians Alliance
Aiken Regional Medical Centers
Cancer Care Institute of Carolina
The Surgery Center of Aiken
North Augusta
ER at Sweetwater
Texas
Alamo
South Texas Health System ER Alamo
Amarillo
Northwest Emergency at Town Square
Northwest Emergency on Georgia
Northwest Physicians Group
Northwest Texas Healthcare System
Anna
ER at Anna
Bonham
TMC Bonham Hospital
Denison
Texoma Medical Center
TexomaCare
Eagle Pass
Fort Duncan Regional Medical Center
Edinburg
Cornerstone Regional Hospital
South Texas Health System Edinburg / South Texas Health System Children's
South Texas Health System ER McColl
South Texas Health System ER Monte Cristo
Laredo
Doctors Hospital Emergency Room Saunders
Doctors Hospital Emergency Room South
Doctors Hospital of Laredo
Laredo Physicians Group
McAllen
South Texas Health System Clinics
South Texas Health System ER Ware Road
South Texas Health System Heart
South Texas Health System McAllen
Mission
South Texas Health System ER Mission
Sherman
ER at Sherman
Weslaco
South Texas Health System ER Weslaco
Behavioral health facilities
UHS also operates over 300 behavioral health facilities in the United States and the United Kingdom, including:
Cygnet Health Care, UK
Psychiatric Institute of Washington, Washington, District of Columbia
Suncoast Behavioral Health Center, Bradenton, Florida
Fuller Hospital, South Attleboro, Massachusetts
Willow Springs Center, Reno, Nevada
Friends Hospital, Philadelphia, Pennsylvania
Provo Canyon School, Provo, Utah
Lancaster Behavioral Health Hospital, Lancaster, PA
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | UHS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 7.25Y avg ≈11.7 | ≈11.7 | 16.5 | Undervalued | |
| PEG Ratio | ≈0.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | UHS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 11.4%5Y avg ≈10.1% | ≈10.1% | 11.9% | Weak | |
| EBITDA Margin | 11.5%5Y avg ≈10.1% | ≈10.1% | 11.1% | In line | |
| Pretax Margin (TTM) | 11.2%5Y avg ≈9.1% | ≈9.1% | 9.8% | In line | |
| Net Profit Margin (TTM) | 8.4%5Y avg ≈6.9% | ≈6.9% | 7.3% | In line | |
| ROA (TTM) | 9.9%5Y avg ≈7.7% | ≈7.7% | 6.5% | Top tier | |
| ROE (TTM) | 21.0%5Y avg ≈17.0% | ≈17.0% | 19.1% | In line | |
| ROIC | 12.7%5Y avg ≈10.8% | ≈10.8% | 13.5% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | UHS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.65Y avg ≈0.7 | ≈0.7 | 0.2 | High debt | |
| Current Ratio (MRQ) | 1.15Y avg ≈1.2 | ≈1.2 | 1.2 | Low liquidity | |
| Quick Ratio | 0.85Y avg ≈1.0 | ≈1.0 | 0.9 | In line | |
| Long-Term Debt / Equity (MRQ) | 0.55Y avg ≈0.7 | ≈0.7 | 0.2 | High debt | |
| Interest Coverage | 12.85Y avg ≈9.2 | ≈9.2 | 7.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | UHS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 9.7%5Y avg ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y | 9.0%5Y avg ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | |
| EPS YoY | 37.3%5Y avg ≈37.9% | ≈37.9% | · | · | |
| Net Income YoY | 30.4%5Y avg ≈31.9% | ≈31.9% | · | · | |
| EPS CAGR 3Y | 36.2%5Y avg ≈15.4% | ≈15.4% | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | |
| Net Income CAGR 3Y | 30.1%5Y avg ≈8.7% | ≈8.7% | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | UHS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.25Y avg ≈1.1 | ≈1.1 | 0.8 | Top tier | |
| Receivables Turnover | 7.35Y avg ≈7.0 | ≈7.0 | 8.4 | Weak | |
| Revenue / Employee | ≈$170.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 1, 2026 | $0.20 | USD | ≈0.47% |
| Jun 8, 2026 | $0.20 | USD | ≈0.56% |
| Mar 2, 2026 | $0.20 | USD | ≈0.39% |
| Dec 1, 2025 | $0.20 | USD | ≈0.33% |
| Sep 2, 2025 | $0.20 | USD | ≈0.44% |
| Jun 2, 2025 | $0.20 | USD | ≈0.43% |
| Mar 3, 2025 | $0.20 | USD | ≈0.46% |
| Dec 3, 2024 | $0.20 | USD | ≈0.40% |
| Sep 3, 2024 | $0.20 | USD | ≈0.34% |
| Jun 3, 2024 | $0.20 | USD | ≈0.43% |
| Feb 29, 2024 | $0.20 | USD | ≈0.48% |
| Nov 30, 2023 | $0.20 | USD | ≈0.58% |
| Aug 31, 2023 | $0.20 | USD | ≈0.59% |
| May 31, 2023 | $0.20 | USD | ≈0.61% |
| Feb 28, 2023 | $0.20 | USD | ≈0.60% |
| Nov 30, 2022 | $0.20 | USD | ≈0.61% |
| Aug 31, 2022 | $0.20 | USD | ≈0.82% |
| May 31, 2022 | $0.20 | USD | ≈0.64% |
| Feb 28, 2022 | $0.20 | USD | ≈0.56% |
| Nov 30, 2021 | $0.20 | USD | ≈0.67% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $5.98 | $6.02 | -0.61% |
| March 31, 2026 | $5.62 | $5.46 | 2.9% | |
| Dec. 31, 2025 | $5.88 | $5.96 | -1.3% | |
| Sept. 30, 2025 | $5.69 | $4.88 | 16.5% | |
| June 30, 2025 | $5.35 | $4.97 | 7.6% | |
| March 31, 2025 | $4.84 | $4.39 | 10.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Operating Expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | |
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | |
| Interest Expense | $156M | $186M | $207M | $127M | $84M | $106M | $163M | $155M | $145M | $125M | $113M | $134M | |
| Other Non-op | $134M | $2M | $-28M | $-10M | $14M | $14.0K | $13M | $14M | $0 | $0 | · | · | |
| Pretax Income | $1.97B | $1.50B | $940M | $866M | $1.29B | $1.25B | $1.07B | $1.03B | $1.14B | $1.16B | $1.15B | $930M | |
| Income Tax | $461M | $335M | $221M | $209M | $306M | $299M | $239M | $237M | $364M | $409M | $395M | $325M | |
| Net Income | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | |
| Shares (Basic) | 63,581,000 | 66,554,000 | 69,321,000 | 73,118,000 | 82,519,000 | 85,061,000 | 88,762,000 | 93,276,000 | 95,652,000 | 97,208,000 | 98,797,000 | 98,826,000 | |
| Shares (Diluted) | 64,462,000 | 67,896,000 | 70,125,000 | 73,832,000 | 83,692,000 | 85,587,000 | 89,040,000 | 93,750,000 | 96,325,000 | 98,380,000 | 100,694,000 | 100,544,000 | |
| EBITDA | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.66B | $1.44B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $126M | $119M | $103M | $115M | $1.22B | $61M | $105M | $74M | $34M | $61M | $32M | |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B | $1.73B | $1.56B | $1.51B | $1.50B | $1.44B | $1.30B | $1.28B | |
| Other Current Assets | $436M | $292M | $237M | $198M | $195M | $138M | $134M | $174M | $87M | $83M | $103M | $78M | |
| Current Assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B | $1.72B | $1.62B | |
| PP&E (Net) | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B | $5.37B | $5.02B | $4.85B | $4.57B | $4.33B | $3.84B | $3.68B | |
| PP&E (Gross) | $13.49B | $12.64B | $11.78B | $11.09B | $10.77B | $9.89B | $9.11B | $8.56B | $7.92B | $7.31B | $6.53B | $6.21B | |
| Accum. Depreciation | $6.48B | $6.07B | $5.65B | $5.17B | $4.90B | $4.51B | $4.09B | $3.72B | $3.35B | $2.98B | $2.69B | $2.53B | |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B | $3.88B | $3.87B | $3.84B | $3.83B | $3.78B | $3.60B | $3.29B | |
| Intangibles | $76M | $76M | $77M | $78M | $81M | $83M | $84M | $173M | $220M | $228M | $219M | $98M | |
| Other Non-current Assets | $5.11B | $5.08B | $5.03B | $5.04B | $4.96B | $4.82B | $4.74B | $4.48B | $4.39B | $4.31B | $4.06B | $3.68B | |
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.95B | |
| Accounts Payable | $750M | $632M | $614M | $637M | $659M | $571M | $447M | $446M | $442M | $440M | $366M | $336M | |
| Current Liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B | $2.48B | $1.56B | $1.45B | $1.85B | $1.32B | $1.10B | $1.18B | |
| Capital Leases | $341M | $376M | $383M | $396M | $305M | $278M | $270M | $18M | $20M | $22M | $23M | · | |
| Deferred Tax | $6M | $0 | · | · | $0 | $6M | $25M | $50M | $55M | $88M | $316M | $168M | |
| Other Non-current Liabilities | $528M | $656M | $584M | $488M | $465M | $459M | $330M | $362M | $306M | $275M | $279M | $269M | |
| Long-term Debt | $4.80B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.43B | $3.28B | |
| Total Debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.45B | $3.28B | |
| Retained Earnings | $7.99B | $7.37B | $6.80B | $6.53B | $6.60B | $6.75B | $5.93B | $5.79B | $5.35B | $4.89B | $4.57B | $4.02B | |
| AOCI | $48M | $7M | $9M | $-10M | $30M | $48M | $32M | $4M | $7M | $-25M | $-23M | $-25M | |
| Stockholders' Equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B | $4.25B | $3.74B | |
| Liabilities + Equity | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.97B |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619M | $585M | $568M | $582M | $533M | $510M | $490M | $453M | $448M | $417M | $399M | $376M | |
| Stock-based Comp | $96M | $99M | $88M | $85M | $74M | $66M | $69M | $67M | $57M | $48M | $40M | $31M | |
| Deferred Tax | $51M | $-33M | $-18M | $-18M | $-30M | $-27M | $-36M | $-10M | $-37M | $-10M | $-11M | $49M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | $-88M | $35M | |
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $996M | $884M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B | $1.07B | $1.04B | |
| CapEx | $1.02B | $944M | $743M | $734M | $856M | $731M | $634M | $665M | $558M | $520M | $379M | $391M | |
| Investing Cash Flow | $-1.07B | $-911M | $-763M | $-647M | $-914M | $-803M | $-688M | $-747M | $-685M | $-1.16B | $-913M | $-833M | |
| Net Debt Issued | $-44M | $-2.64B | $-85M | $-89M | $-3.04B | $-963M | $-57M | $-830M | $-143M | $-459M | $-68M | $-879M | |
| Stock Issued | $17M | $15M | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $10M | $8M | $7M | |
| Stock Repurchased | $968M | $671M | $547M | $833M | $1.22B | $207M | $771M | $397M | $364M | $353M | $210M | $101M | |
| Net Stock Activity | $-951M | $-656M | $-534M | $-819M | $-1.21B | $-194M | $-760M | $-387M | $-354M | $-344M | $-201M | $-94M | |
| Dividends Paid | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M | |
| Financing Cash Flow | $-750M | $-1.14B | $-494M | $-318M | $-1.07B | $-385M | $-845M | $-492M | $-519M | $-171M | $-125M | $-187M | |
| Net Change in Cash | $47M | $10M | $14M | $22M | $-1.10B | $1.17B | $-94M | $32M | $45M | $5M | $29M | $15M | |
| Taxes Paid | $471M | $325M | $258M | $251M | $363M | $286M | $261M | $294M | $371M | $345M | $381M | $259M | |
| Free Cash Flow | $849M | $1.12B | $525M | $262M | $28M | $1.63B | $804M | $676M | $625M | $769M | $642M | $645M | |
| Levered FCF | $730M | $979M | $367M | $166M | $-36M | $1.55B | $678M | $556M | $526M | $688M | $567M | $558M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.2% | |
| Net Margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.8% | |
| Pretax Margin | 11.4% | 9.5% | 6.6% | 6.5% | 10.2% | 10.8% | 9.4% | 9.6% | 10.9% | 11.8% | 12.7% | 11.5% | |
| EBITDA Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 18.3% | 17.8% | |
| ROA | 9.9% | 8.0% | 5.2% | 5.0% | 7.6% | 7.1% | 7.0% | 6.9% | 7.0% | 7.0% | 7.2% | 6.1% | |
| ROE | 21.4% | 17.8% | 11.9% | 11.2% | 16.0% | 16.0% | 15.0% | 15.0% | 15.8% | 16.0% | 17.0% | 15.6% | |
| ROIC | 12.7% | 11.7% | 8.1% | 7.1% | 10.1% | 10.2% | 10.0% | 9.7% | 9.6% | 9.6% | 10.7% | 9.9% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | 1.4 | 1.3 | 1.1 | 1.3 | 1.2 | 1.3 | 1.0 | 1.3 | 1.6 | 1.4 | |
| Quick Ratio | 0.8 | 1.0 | 1.2 | 1.1 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | |
| Interest Coverage | 12.8 | 9.0 | 5.7 | 7.9 | 16.3 | 12.8 | 7.5 | 7.6 | 8.8 | 10.2 | 11.1 | 8.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | |
| Receivables Turnover | 7.3 | 7.2 | 6.7 | 7.1 | 7.3 | 7.0 | 7.4 | 7.2 | 7.1 | 7.1 | 7.0 | 6.7 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $269.38 | $233.12 | $203.66 | $181.48 | $151.06 | $135.05 | $127.79 | $114.90 | $108.07 | $99.27 | $89.81 | $80.22 | |
| Cash Flow / Share | $28.92 | $30.45 | $18.08 | $13.49 | $10.56 | $27.58 | $16.16 | $14.30 | $12.28 | $13.10 | $10.14 | $10.30 | |
| Dividend Paid / Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | · | $0.60 | $0.40 | · | · | · | $0.30 | |
| EPS (TTM) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.0% | 7.8% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 37.3% | 64.4% | 11.9% | -22.7% | 7.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.2% | 12.5% | -2.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.4% | 59.1% | 6.2% | -31.9% | 5.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 30.1% | 4.8% | -8.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 24.2% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Net Income TTM | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| P/E | 9.4 | 10.7 | 14.9 | 15.4 | 11.0 | 12.5 | 15.7 | 14.0 | 14.5 | 14.9 | 17.7 | 20.5 | |
| Earnings Yield | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% | 5.7% | 4.9% | |
| Payout Ratio | 3.4% | 4.7% | 7.7% | 8.6% | 6.7% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% | 5.8% | 5.4% | |
| Annual Payout | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B | $3.55B | $3.47B | $3.45B | $3.34B | |
| Operating Expenses | $4.12B | $3.99B | $3.97B | $3.97B | $3.78B | $3.64B | $3.64B | $3.58B | $3.47B | $3.45B | $3.37B | $3.28B | $3.27B | $3.19B | $3.19B | $3.06B | |
| Operating Income | $517M | $503M | $517M | $522M | $500M | $455M | $472M | $384M | $436M | $389M | $331M | $285M | $280M | $279M | $261M | $276M | |
| Interest Expense | $40M | $37M | $42M | $38M | $35M | $40M | $40M | $45M | $49M | $53M | $54M | $53M | $49M | $51M | $44M | $36M | |
| Other Non-op | $2M | $3M | $106M | $14M | $8M | $6M | $6M | $2M | $-5M | $150.0K | $4M | $-11M | $-7M | $-14M | $5M | $-6M | |
| Pretax Income | $479M | $469M | $581M | $497M | $473M | $420M | $438M | $342M | $382M | $336M | $281M | $221M | $225M | $214M | $222M | $234M | |
| Income Tax | $115M | $110M | $134M | $118M | $111M | $99M | $101M | $76M | $88M | $70M | $62M | $52M | $55M | $52M | $52M | $57M | |
| Net Income | $358M | $349M | $446M | $373M | $353M | $317M | $332M | $259M | $289M | $262M | $216M | $167M | $171M | $163M | $175M | $183M | |
| EPS (Basic) | $6.01 | $5.71 | $7.14 | $5.92 | $5.49 | $4.87 | $5.05 | $3.89 | $4.32 | $3.90 | $3.18 | $2.42 | $2.44 | $2.31 | $2.44 | $2.52 | |
| EPS (Diluted) | $5.98 | $5.65 | $7.01 | $5.86 | $5.43 | $4.80 | $4.94 | $3.80 | $4.26 | $3.82 | $3.13 | $2.40 | $2.42 | $2.28 | $2.42 | $2.50 | |
| Shares (Basic) | 59,657,000 | 61,071,000 | · | 62,974,000 | 64,356,000 | 64,970,000 | · | 66,537,000 | 66,878,000 | 67,204,000 | · | 68,867,000 | 70,073,000 | 70,535,000 | · | 72,595,000 | |
| Shares (Diluted) | 59,910,000 | 61,668,000 | · | 63,663,000 | 64,991,000 | 66,037,000 | · | 68,108,000 | 67,920,000 | 68,482,000 | · | 69,624,000 | 70,839,000 | 71,487,000 | · | 73,060,000 | |
| EBITDA | $517M | $503M | · | $522M | $500M | $455M | · | $384M | $436M | $389M | · | $285M | $280M | $279M | · | $276M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $119M | $138M | $113M | $138M | $127M | $126M | $106M | $129M | $112M | $119M | $81M | $79M | $110M | $103M | $75M | |
| Receivables | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | · | $2.23B | $2.10B | $2.03B | · | $1.90B | |
| Other Current Assets | $505M | $406M | $436M | $333M | $327M | $317M | $292M | $262M | $236M | $243M | · | $223M | $226M | $201M | · | $262M | |
| Current Assets | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | · | $2.75B | $2.62B | $2.56B | · | $2.46B | |
| PP&E (Net) | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B | $6.44B | $6.33B | $6.18B | · | $6.09B | $6.03B | $5.95B | · | $5.94B | |
| PP&E (Gross) | $13.83B | $13.61B | · | $13.45B | $13.24B | $12.91B | · | $12.45B | $12.24B | $11.96B | · | $11.61B | $11.44B | $11.25B | · | $11.10B | |
| Accum. Depreciation | $6.69B | $6.55B | $6.48B | $6.48B | $6.35B | $6.21B | $6.07B | $6.01B | $5.91B | $5.77B | · | $5.52B | $5.41B | $5.30B | · | $5.17B | |
| Goodwill | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B | $3.97B | $3.94B | $3.93B | $3.93B | $3.91B | $3.93B | $3.91B | $3.91B | $3.87B | |
| Intangibles | · | · | $76M | · | · | · | $76M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $5.11B | · | · | · | $5.08B | · | · | · | · | · | · | · | · | · | |
| Total Assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B | |
| Accounts Payable | · | · | $750M | · | · | · | $632M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | · | $1.99B | $2.04B | $1.86B | · | $1.94B | |
| Capital Leases | $339M | $345M | $341M | $346M | $352M | $369M | $376M | $378M | $380M | $374M | · | $389M | $388M | $396M | · | $393M | |
| Deferred Tax | $3M | $3M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $560M | $533M | $528M | $590M | $629M | $682M | $656M | $660M | $570M | $551M | · | $588M | $571M | $532M | · | $500M | |
| Long-term Debt | $4.90B | $4.70B | $4.75B | $4.70B | $4.60B | $4.60B | $4.50B | $4.70B | $4.50B | $4.90B | · | $4.90B | $4.70B | $4.80B | · | $4.70B | |
| Total Debt | $4.85B | $4.71B | · | $4.69B | $4.58B | $4.65B | · | $4.66B | $4.54B | $4.86B | · | $4.92B | $4.72B | $4.80B | · | $4.70B | |
| Retained Earnings | · | · | $7.99B | · | · | · | $7.37B | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $48M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | · | $6.06B | $6.09B | $6.01B | · | $5.86B | |
| Liabilities + Equity | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $155M | $163M | $155M | $152M | $148M | $147M | $150M | $147M | $141M | $145M | $137M | $144M | $142M | $148M | $146M | |
| Stock-based Comp | $23M | $23M | $25M | $25M | $24M | $22M | $27M | $27M | $27M | $20M | $22M | $23M | $22M | $21M | $23M | $21M | |
| Operating Cash Flow | $443M | $402M | $575M | $381M | $549M | $360M | $658M | $333M | $679M | $396M | $452M | $162M | $363M | $291M | $297M | $221M | |
| CapEx | $228M | $217M | $281M | $229M | $266M | $239M | $246M | $248M | $241M | $209M | $206M | $200M | $168M | $169M | $164M | $162M | |
| Investing Cash Flow | $-234M | $-198M | $-224M | $-269M | $-306M | $-271M | $-208M | $-266M | $-243M | $-195M | $-239M | $-176M | $-170M | $-178M | $-248M | $-73M | |
| Net Debt Issued | · | $-45M | · | · | · | $-9M | · | · | · | $-64M | · | · | · | $-16M | · | · | |
| Stock Issued | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Stock Repurchased | $321M | $164M | $352M | $237M | $155M | $223M | $250M | $183M | $96M | $142M | $162M | $176M | $125M | $85M | $110M | $158M | |
| Net Stock Activity | · | $-160M | · | · | · | $-220M | · | · | · | $-139M | · | · | · | $-82M | · | · | |
| Dividends Paid | $12M | $13M | $12M | $12M | $13M | $14M | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $15M | |
| Financing Cash Flow | $-189M | $-222M | $-296M | $-135M | $-228M | $-91M | $-427M | $-90M | $-420M | $-209M | $-182M | $18M | $-224M | $-106M | $-15M | $-179M | |
| Net Change in Cash | $20M | $-19M | $55M | $-25M | $18M | $-1M | $20M | $-19M | $17M | $-8M | $34M | $1M | $-30M | $8M | $35M | $-37M | |
| Taxes Paid | $189M | $8M | $115M | $104M | $246M | $6M | $88M | $105M | $129M | $3M | $67M | $57M | $131M | $2M | $69M | $37M | |
| Free Cash Flow | · | $184M | · | · | · | $121M | · | · | · | $188M | · | · | · | $122M | · | · | |
| Levered FCF | · | $156M | · | · | · | $90M | · | · | · | $146M | · | · | · | $83M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| Net Margin | 7.7% | 7.8% | · | 8.3% | 8.2% | 7.7% | · | 6.5% | 7.4% | 6.8% | · | 4.7% | 4.8% | 4.7% | · | 5.5% | |
| Pretax Margin | 10.3% | 10.4% | · | 11.1% | 11.1% | 10.3% | · | 8.6% | 9.8% | 8.7% | · | 6.2% | 6.3% | 6.2% | · | 7.0% | |
| EBITDA Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| ROA | 2.3% | 2.3% | · | 2.5% | 2.4% | 2.2% | · | 1.8% | 2.1% | 1.9% | · | 1.2% | 1.3% | 1.2% | · | 1.4% | |
| ROE | 4.9% | 4.9% | · | 5.4% | 5.2% | 4.9% | · | 4.1% | 4.6% | 4.3% | · | 2.8% | 2.9% | 2.8% | · | 3.0% | |
| ROIC | 3.2% | 3.2% | · | 3.4% | 3.3% | 3.0% | · | 2.7% | 3.0% | 2.8% | · | 2.0% | 1.9% | 1.9% | · | 2.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.0 | 1.3 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 12.9 | 13.5 | · | 13.6 | 14.1 | 11.4 | · | 8.6 | 8.9 | 7.4 | · | 5.3 | 5.7 | 5.5 | · | 7.7 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 1.8 | 1.8 | · | 1.7 | 1.8 | 1.8 | · | 1.8 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $77.42 | $72.89 | · | $70.61 | $65.91 | $62.08 | · | $58.19 | $57.53 | $56.13 | · | $51.17 | $50.09 | $48.51 | · | $45.66 | |
| Cash Flow / Share | · | $6.51 | · | · | · | $5.45 | · | · | · | $5.79 | · | · | · | $4.07 | · | · | |
| Dividend Paid / Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $24.50 | $23.95 | · | $21.03 | $18.97 | $17.80 | · | $15.01 | $13.61 | $11.77 | · | $9.52 | $9.62 | $9.40 | · | $9.72 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.11B | $17.76B | · | $16.99B | $16.46B | $16.08B | · | $15.42B | $15.02B | $14.66B | · | $14.03B | $13.80B | $13.57B | · | $13.23B | |
| Net Income TTM | $1.53B | $1.52B | · | $1.38B | $1.26B | $1.20B | · | $1.03B | $934M | $817M | · | $676M | $692M | $685M | · | $740M | |
| P/E | 6.1 | 7.5 | · | 9.7 | 9.5 | 10.6 | · | 15.3 | 13.6 | 15.5 | · | 13.2 | 16.4 | 13.5 | · | 9.1 | |
| Earnings Yield | 16.5% | 13.4% | · | 10.3% | 10.5% | 9.5% | · | 6.6% | 7.4% | 6.5% | · | 7.6% | 6.1% | 7.4% | · | 11.0% | |
| Payout Ratio | · | 3.7% | · | · | · | 4.3% | · | · | · | 5.2% | · | · | · | 8.7% | · | · | |
| Annual Payout | $50M | $51M | · | $52M | $53M | $53M | · | $54M | $54M | $55M | · | $56M | $57M | $58M | · | $60M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | · | · |
| Operating Margin % | 11.5% | 10.6% | 8.2% | · | · |
| Net Income | $1.49B | $1.14B | $718M | · | · |
| Diluted EPS | $23.10 | $16.82 | $10.23 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Debt / Equity | 0.7 | 0.7 | 0.8 | · | · |
| Current Ratio | 1.1 | 1.3 | 1.4 | · | · |
| Quick Ratio | 0.8 | 1.0 | 1.2 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $849M | $1.12B | $525M | · | · |
Institutional owners (13F) 642 filers · $9.0B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 73 (-10 vs prior Q) | 122 (+33 vs prior Q) | 215 (-37 vs prior Q) | 240 (+8 vs prior Q) | +2.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1,414,195,886 | 6,486,542 | 15.65% | Shares |
| First Eagle Investment Management, LLC | $677,233,918 | 4,554,670 | 7.49% | Shares |
| BlackRock, Inc. | $603,655,463 | 4,059,826 | 6.68% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $504,386,069 | 3,392,199 | 5.58% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $364,614,198 | 2,452,177 | 4.03% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $328,686,665 | 2,210,595 | 3.64% | Shares |
| STATE STREET CORP | $312,637,527 | 2,102,613 | 3.46% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $293,152,556 | 1,974,065 | 3.24% | Shares |
| PZENA INVESTMENT MANAGEMENT LLC | $292,819,232 | 1,969,327 | 3.24% | Shares |
| Invesco Ltd. | $290,116,048 | 1,951,147 | 3.21% | Shares |
| FMR LLC | $210,657,318 | 1,416,755 | 2.33% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $210,522,439 | 1,415,848 | 2.33% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $158,819,352 | 1,068,124 | 1.76% | Shares |
| AMERICAN CENTURY COMPANIES INC | $140,451,548 | 944,592 | 1.55% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $135,479,763 | 906,103 | 1.50% | Shares |
| NORGES BANK | $132,110,916 | 888,499 | 1.46% | Shares |
| MORGAN STANLEY | $111,481,141 | 749,754 | 1.23% | Shares |
| GOLDMAN SACHS GROUP INC | $89,504,438 | 601,953 | 0.99% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85,524,258 | 575,185 | 0.95% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $83,716,782 | 563,029 | 0.93% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $76,891,019 | 523,210 | 0.85% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $75,911,300 | 510,534 | 0.84% | Shares |
| NORTHERN TRUST CORP | $67,032,574 | 450,821 | 0.74% | Shares |
| Invenomic Capital Management LP | $63,529,884 | 427,264 | 0.70% | Shares |
| MILLENNIUM MANAGEMENT LLC | $62,058,597 | 417,369 | 0.69% | Shares |
| Qube Research & Technologies Ltd | $59,094,313 | 397,433 | 0.65% | Shares |
| MACKENZIE FINANCIAL CORP | $56,636,764 | 380,905 | 0.63% | Shares |
| Ranmore Fund Management Ltd | $56,501,159 | 379,993 | 0.63% | Shares |
| Allianz Asset Management GmbH | $56,202,738 | 377,986 | 0.62% | Shares |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $52,580,501 | 353,625 | 0.58% | Shares |
| UBS Group AG | $49,695,321 | 334,221 | 0.55% | Shares |
| CITADEL ADVISORS LLC | $45,818,377 | 308,147 | 0.51% | Shares |
| Quantinno Capital Management LP | $45,782,797 | 307,907 | 0.51% | Shares |
| Bank of New York Mellon Corp | $44,605,741 | 299,992 | 0.49% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $44,371,846 | 300,663 | 0.49% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $44,081,678 | 296,467 | 0.49% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42,437,187 | 237,119 | 0.47% | Shares |
| Khrom Capital Management LLC | $39,401,958 | 264,994 | 0.44% | Shares |
| Russell Investments Group, Ltd. | $37,642,835 | 253,289 | 0.42% | Shares |
| Bridgewater Associates, LP | $33,919,311 | 228,121 | 0.38% | Shares |
| SEI INVESTMENTS CO | $33,100,670 | 222,614 | 0.37% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $33,071,927 | 222,422 | 0.37% | Shares |
| Allspring Global Investments Holdings, LLC | $32,949,468 | 218,817 | 0.36% | Shares |
| DEUTSCHE BANK AG\ | $31,202,151 | 209,847 | 0.35% | Shares |
| FIRST TRUST ADVISORS LP | $31,057,609 | 208,876 | 0.34% | Shares |
| CARRONADE CAPITAL MANAGEMENT, LP | $29,738,000 | 200,000 | 0.33% | Shares |
| JPMORGAN CHASE & CO | $29,603,947 | 198,975 | 0.33% | Shares |
| Arbejdsmarkedets Tillaegspension | $28,712,039 | 193,100 | 0.32% | Shares |
| FRANKLIN RESOURCES INC | $28,049,718 | 188,646 | 0.31% | Shares |
| BARCLAYS PLC | $27,758,340 | 186,686 | 0.31% | Shares |
Company insiders 24 insiders · 10 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Marc D Miller | President and CEO | March 26, 2026 A | 388,621 | 0 | 0 | $0 |
| Steve Filton | Executive Vice President & CFO | March 26, 2026 A | 144,715 | 0 | 0 | $0 |
| Alan B Miller | Executive Chairman | May 27, 2026 J | 25,495 | 0 | 0 | $0 |
| Edward H Sim | Executive Vice President | March 26, 2026 A | 24,790 | 0 | 0 | $0 |
| Matthew Jay Peterson | Executive Vice President, UHS | March 26, 2026 A | 31,984 | 0 | 0 | $0 |
| Marvin G. Pember | Executive Vice President | March 23, 2022 A | 36,599 | 0 | 0 | $0 |
| Debra K Osteen | Executive Vice President | April 13, 2018 A | 93,174 | 0 | 0 | $0 |
| Richard C Wright | Vice President | Nov. 26, 2012 S | 0 | 0 | 0 | $0 |
| Michael Marquez | Senior Vice President | June 4, 2010 M | 28,525 | 0 | 0 | $0 |
| Kevin J Gross | Senior Vice President | May 31, 2007 M | 623 | 0 | 0 | $0 |
| Nina Chen-Langenmayr | Director | May 20, 2026 A | 4,267 | 0 | 0 | $0 |
| Maria Ruderman Singer | Director | May 20, 2026 A | 9,792 | 0 | 0 | $0 |
| Warren J. Nimetz | Director | May 20, 2026 A | 9,698 | 0 | 2 | $-852,356 |
| Eileen C. Mcdonnell | Director | May 20, 2026 A | 9,406 | 0 | 0 | $0 |
| Elliot J Md Mba Sussman | Director | May 20, 2026 A | 7,330 | 0 | 3 | $-345,899 |
| Lawrence S. Gibbs | Director | March 7, 2023 S | 2,230 | 0 | 0 | $0 |
| Robert H Hotz | Director | July 29, 2019 M | 52,715 | 0 | 0 | $0 |
| John H Herrell | Director | May 15, 2018 M | 19,274 | 0 | 0 | $0 |
| Anthony Pantaleoni | Director | Nov. 29, 2017 M | 1,794 | 0 | 0 | $0 |
| Leatrice Ducat | Director | March 5, 2013 M | 4,000 | 0 | 0 | $0 |
| Richard J Santorum | Director | May 16, 2011 M | 7,437 | 0 | 0 | $0 |
| Daniel B. Silvers | Director | May 3, 2011 M | 2,048 | 0 | 0 | $0 |
| John F Williams JR | Director | Nov. 21, 2008 A | 3,975 | 0 | 0 | $0 |
| Robert A Meister | Director | Nov. 21, 2007 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 104 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2.57% | 159,598 NS | July 31, 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2.14% | 922 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.64% | 81,839 SH | Oct. 2, 2026 | Daily |
| CVSM · Elevation Series Trust | 1.59% | 8,938 NS | July 31, 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.52% | 176,775 SH | Oct. 2, 2026 | Daily |
| IHF · iShares Trust | 1.35% | 102,351 SH | Sept. 11, 2026 | Daily |
| RNIN · EA Series Trust | 1.29% | 13,918 NS | July 31, 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1.09% | 64,307 NS | July 31, 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1.04% | 13,049 NS | July 31, 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 0.95% | 15,263 NS | July 31, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.80% | 10,896 NS | July 31, 2026 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0.54% | 23,720 NS | July 31, 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.49% | 43,874 NS | July 31, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.44% | 42,101 SH | Oct. 2, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.42% | 34,637 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.40% | 345,907 NS | July 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.31% | 29,880 SH | Oct. 2, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.31% | 151,188 NS | July 31, 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.28% | 7,534 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 7,517 NS | July 31, 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.24% | 2,408 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1,110,425 SH | Oct. 2, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.20% | 7,667 NS | July 31, 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.19% | 5,968,000 | Oct. 2, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 22,463 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 27,092 NS | July 31, 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0.18% | 107,089 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.16% | 737,146 SH | Aug. 19, 2026 | Daily |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.16% | 220,000 | Oct. 2, 2026 | Daily |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 7,588 NS | July 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.15% | 8,469 SH | Aug. 19, 2026 | Daily |
| IYH · iShares Trust | 0.14% | 29,765 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 24,277 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.12% | 27,226 SH | Sept. 11, 2026 | Daily |
| LGDX · Tidal Trust III | 0.12% | 1,016 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.12% | 28,234 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.12% | 105,486 NS | July 31, 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.11% | 3,422,000 | Oct. 2, 2026 | Daily |
| NFRA · FlexShares Trust | 0.11% | 20,262 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.11% | 153,595 SH | Aug. 19, 2026 | Daily |
| GLOF · iShares Trust | 0.11% | 1,247 SH | Sept. 11, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.10% | 1,049 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 4,377 SH | Oct. 2, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.09% | 3,027 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.09% | 51,324 SH | Oct. 2, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.09% | 1,161,113 SH | Aug. 19, 2026 | Daily |
| IWS · iShares Trust | 0.09% | 75,629 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.08% | 3,240 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.08% | 9,796 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.07% | 4,082 SH | Oct. 2, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.07% | 25,532 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.06% | 208,577 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.06% | 53,251 NS | July 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.05% | 67 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.05% | 28,658 SH | Oct. 2, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.04% | 107,516 NS | July 31, 2026 | N-PORT |
| IVE · iShares Trust | 0.03% | 88,425 SH | Sept. 11, 2026 | Daily |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 12,323 SH | Aug. 19, 2026 | Daily |
| IUSV · iShares Trust | 0.03% | 46,100 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.03% | 5,685 NS | July 31, 2026 | N-PORT |
| IWD · iShares Trust | 0.02% | 112,974 SH | Sept. 11, 2026 | Daily |
| EGLE · Global X Funds | 0.02% | 3 NS | July 31, 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 30,745 SH | Aug. 19, 2026 | Daily |
| DYNF · BlackRock ETF Trust | 0.02% | 45,056 SH | Sept. 11, 2026 | Daily |
| TOPC · iShares Trust | 0.02% | 33 SH | Sept. 11, 2026 | Daily |
| XVV · iShares Trust | 0.02% | 647 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 11,778 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.02% | 58 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.02% | 2,904 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.01% | 44 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.01% | 2,808 NS | July 31, 2026 | N-PORT |
| XCLR · Global X Funds | 0.01% | 3 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.01% | 671,648 SH | Sept. 11, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 308 SH | Oct. 1, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 3,713 SH | Oct. 2, 2026 | Daily |
| IWB · iShares Trust | 0.01% | 36,488 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.01% | 2,238 SH | Sept. 11, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.01% | 201 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.01% | 14,744 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.01% | 1,283 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 68,363 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.01% | 14,968 NS | July 31, 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 42 SH | Oct. 2, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.01% | 369 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.01% | 3 NS | July 31, 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 4,165 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 1,383,774 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1,606,967 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 41,234 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8,402 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 4,280 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.01% | 11,510 SH | Aug. 19, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.01% | 882 SH | Oct. 2, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.00% | 636 NS | July 31, 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 3,000 | Sept. 30, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| ISCB · iShares Trust | · | 2,307 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 11,393 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 2,436 SH | Sept. 1, 2026 | Daily |
UHS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
17 analysts · 2026-09-27Mean target $194.35 +10.6%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.